RABENOSYN separation-of-function mutations uncouple endosomal recycling from lysosomal degradation, causing a distinct Mendelian disorder.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
28 10 2022
Historique:
received: 01 04 2022
revised: 12 05 2022
accepted: 19 05 2022
pubmed: 3 6 2022
medline: 2 11 2022
entrez: 2 6 2022
Statut: ppublish

Résumé

Rabenosyn (RBSN) is a conserved endosomal protein necessary for regulating internalized cargo. Here, we present clinical, genetic, cellular and biochemical evidence that two distinct RBSN missense variants are responsible for a novel Mendelian disorder consisting of progressive muscle weakness, facial dysmorphisms, ophthalmoplegia and intellectual disability. Using exome sequencing, we identified recessively acting germline alleles p.Arg180Gly and p.Gly183Arg, which are both situated in the FYVE domain of RBSN. We find that these variants abrogate binding to its cognate substrate phosphatidylinositol 3-phosphate (PI3P) and thus prevent its translocation to early endosomes. Although the endosomal recycling pathway was unaltered, mutant p.Gly183Arg patient fibroblasts show accumulation of cargo tagged for lysosomal degradation. Our results suggest that these variants are separation-of-function alleles, which cause a delay in endosomal maturation without affecting cargo recycling. We conclude that distinct germline mutations in RBSN cause non-overlapping phenotypes with specific and discrete endolysosomal cellular defects.

Identifiants

pubmed: 35652444
pii: 6597095
doi: 10.1093/hmg/ddac120
doi:

Substances chimiques

RBSN protein, human 0
Vesicular Transport Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3729-3740

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Franziska Paul (F)

Laboratory of Human Genetics & Therapeutics, Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore.

Calista Ng (C)

Laboratory of Human Genetics & Therapeutics, Genome Institute of Singapore (GIS), A*STAR, Singapore.

Umar Bin Mohamad Sahari (UB)

Laboratory of Human Genetics & Therapeutics, Genome Institute of Singapore (GIS), A*STAR, Singapore.

Shahriar Nafissi (S)

Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Yalda Nilipoor (Y)

Pediatric Pathology Research Centre, Research Institute for Children Health, Shahid Beheshti Medical University, Tehran, Iran.

Ali Reza Tavasoli (AR)

Myelin Disorders Clinic, Pediatric Neurology Division, Children's Medical Center, Tehran University Of Medical Sciences, Tehran, Iran.

Carine Bonnard (C)

Model Development, A*STAR Skin Research Labs (ASRL), Singapore.

Pui-Mun Wong (PM)

Laboratory of Human Genetics & Therapeutics, Genome Institute of Singapore (GIS), A*STAR, Singapore.

Nasrinsadat Nabavizadeh (N)

Laboratory of Human Genetics & Therapeutics, Genome Institute of Singapore (GIS), A*STAR, Singapore.
Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.
Department of Medical Genetics, Koç University School of Medicine, Istanbul, Turkey.

Umut Altunoğlu (U)

Department of Medical Genetics, Koç University School of Medicine, Istanbul, Turkey.

Mehrdad A Estiar (MA)

Department of Human Genetics, McGill University, Montréal, Québec, Canada.
The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montréal, Québec, Canada.

Charles B Majoie (CB)

Department of Radiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Hane Lee (H)

3billion Inc., Seoul, South Korea.
Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

Stanley F Nelson (SF)

Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

Ziv Gan-Or (Z)

Department of Human Genetics, McGill University, Montréal, Québec, Canada.
The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montréal, Québec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.

Guy A Rouleau (GA)

Department of Human Genetics, McGill University, Montréal, Québec, Canada.
The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montréal, Québec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.

Paul P Van Veldhoven (PP)

Laboratory of Lipid Biochemistry and Protein Interactions (LIPIT), Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.

Rami Massie (R)

The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montréal, Québec, Canada.
Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.

Raoul C Hennekam (RC)

Department of Pediatrics, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Ariana Kariminejad (A)

Kariminejad-Najmabadi Pathology & Genetics Centre, Tehran, Iran.

Bruno Reversade (B)

Laboratory of Human Genetics & Therapeutics, Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore.
Laboratory of Human Genetics & Therapeutics, Genome Institute of Singapore (GIS), A*STAR, Singapore.
Department of Medical Genetics, Koç University School of Medicine, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH